April 16 (Reuters) - GSK plc:
* PRESCRIPTION DRUG USER FEE ACT ACTION DATE SET BY FDA FOR 14 FEBRUARY 2025
* FDA ACCEPTS GSK MENINGITIS VACCINE CANDIDATE FILE
* SUBMISSION BASED ON RESULTS FROM PIVOTAL PHASE III TRIAL SHOWING ALL PRIMARY ENDPOINTS MET Source text for Eikon: Further company coverage: